GOING TO BE REALOpts I always welcome your comments and opinions. I only meant that while listening to interviews and reading articles, over the last few months, on numerous occasions the topic of low market cap, and share price was brought up, questioning the reason why the company was not competing with medium tier companies.
I agree with most of your messages, but we obviously have different investing styles, hence the different approach and mind set when addressing supreme.
In my opinion Supreme has all the available tools to be competing with the medium tier companies, but at this stage I personnaly value market reaction, which with small cap companies is the driving force to achieve the desired momentum. Once we reach the 5 to 7 SP, fundementals, and financials will be driving this company.
I strongly believe that if the company is fully prepared to embrace the recretional market, as the leading producer of premium cannabis at scale, now is the time to start claiming the market cap and SP for such a company.
I don't know how many other companies will be operating at full capacity before the end of 2019. This company should be entering 2020 as a $300,000,000.00 company, meaning $75,000,000.00 per quarter. That's not counting Lesotho, or lot 16, therefore in my opinion we should finish the year in the top 5 to 10, and be at the 5 to 7 SP, which should be grown organically, and putting the RS to rest.
There is no reason why this company should not be competing with the likes of Organigram by Q4.
Imho